1992
DOI: 10.1111/j.1748-1716.1992.tb09286.x
|View full text |Cite
|
Sign up to set email alerts
|

Myogenic vascular regulation in skeletal muscle in vivo is not dependent of endothelium‐derived nitric oxide

Abstract: The hypothesis, based on in vitro experiments on large conduit arteries, that endothelium-derived nitric oxide is a mediator of vascular myogenic reactivity was tested in cat gastrocnemius muscle in vivo. This was done by comparing, in the absence and presence of effective endothelium-derived nitric oxide blockade by the specific inhibitors NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester, myogenic responses in defined consecutive vascular sections to dynamic vascular transmural pressure stimuli, t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
31
0

Year Published

1994
1994
2021
2021

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(37 citation statements)
references
References 19 publications
6
31
0
Order By: Relevance
“…The NO responsible is largely produced by nNOS in macula densa cells (154,192,210). Although NO has also been reported to attenuate MR in vessels from skin (63), myocardium (151,158,198), mesentery (150), spleen (25), and skeletal muscle (46,93,141), other studies failed to confirm such an effect at least in the skeletal muscle circulation (50,51,97,184). The picture is even less consistent in the kidney.…”
Section: Modulation Of the Contribution Of The Autoregulatory Mechanismsmentioning
confidence: 99%
“…The NO responsible is largely produced by nNOS in macula densa cells (154,192,210). Although NO has also been reported to attenuate MR in vessels from skin (63), myocardium (151,158,198), mesentery (150), spleen (25), and skeletal muscle (46,93,141), other studies failed to confirm such an effect at least in the skeletal muscle circulation (50,51,97,184). The picture is even less consistent in the kidney.…”
Section: Modulation Of the Contribution Of The Autoregulatory Mechanismsmentioning
confidence: 99%
“…This profile contrasts with that found in the current study. Ekelund et al (1992) used the a-adrenoceptor agonist phenylephrine to control for the hypertensive effect of NO synthase inhibition upon responses. The pharmacodynamic profile of phenylephrine may be different from that of NO synthase inhibitors and is therefore not the best means of controlling for the loss of endogenous levels of NO.…”
Section: Discussionmentioning
confidence: 99%
“…A component of the autoregulatory adjustment is termed the myogenic response, which was first identified by Bayliss in 1902 (15,38). This response can occur independent of sympathetic and endothelium influences (13,50).…”
mentioning
confidence: 94%